Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Decorative image

19th International Conference on Endothelin (ET‑19)

Past Event
September 21-24, 2025

Topics: Nephrology

Location: Charleston, South Carolina
Type: In-person
Share:
Home » Meetings & Events » ET-19 2025



The International Conference on Endothelin is a biannual biomedical meeting that presents the latest in basic and clinical science on endothelin and endothelin receptor antagonists (ERAs).

Travere at ET-19

Travere Therapeutics was excited to participate in the 19th International Conference on Endothelin and engage with scientists and renal healthcare professionals from around the world. We look forward to seeing you next year.


Program

Nephrology

Urinary Biomarker Analysis Reveals Rapid Intrarenal Anti-Inflammatory and Anti-Fibrotic Effects of Sparsentan (SPAR) in IgA Nephropathy (IgAN) in the SPARTAN Study

Speakers: Chee Kay Cheung, William A Barratt, Sulalita Chaki, Silpa Chinnakotla, Neeraj Dhaun, Siân Griffin, Bruce Hendry, Amal A A Jama, Wenjun Ju, Ishika Khan, Radko Komers, Alex Mercer, Viji Nair, Nadia Nawaz, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Matthias Kretzler, Jonathan Barratt

Visual summary and presentation: View
Presentation: View
Travere MSLs

Meet a Travere MSL

Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.

Contact an MSL
Nephrology

Sparsentan (SPAR) as First-Line Treatment of Incident Patients (Pts) With IgA Nephropathy (IgAN): An Interim Analysis of the SPARTAN Trial Evaluating Efficacy and Cardiovascular (CV) Risk Variables

Speakers: Chee Kay Cheung, Stephanie Moody, Neeraj Dhaun, Matthew Graham-Brown, Siân Griffin, Alexandra Howson, Radko Komers, Bruce Hendry, Alex Mercer, Kelly Parke, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt, Lisa Willcocks, Matthias Kretzler, Jonathan Barratt
Summary Coming Soon

Presentation: View
Nephrology

Patients (Pts) With Focal Segmental Glomerulosclerosis (FSGS) Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan (SPAR) vs Irbesartan (IRB) in DUPLEX

Speakers: Bruce Hendry, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Laura Kooienga, Radko Komers, Jula Inrig, Edward Murphy, Eva Rodríguez García

Presentation: View
Nephrology

Sparsentan Reversibly Decreases Mesangial IgA Deposition in gddY Mice: A Possible Role for Mesangial-Cell-Surface Autoantigen Expression

Speakers: Kazuaki Mori, Yoshihito Nihei, Celia Jenkinson, Bruce Hendry, Hitoshi Suzuki, Yusuke Suzuki

Poster: View

MA-DS-25-0076 | August 2025